Tower Research Capital LLC (Trc) Cytek Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,402 shares of CTKB stock, worth $12,826. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,402
Previous 17,054
85.92%
Holding current value
$12,826
Previous $95,000
86.32%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CTKB
# of Institutions
143Shares Held
72.8MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$91.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$62.9 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$50.7 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$35.5 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$22.3 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $719M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...